Catalyst Wire Dossier Catalyst Wire Dossier

ASP1617

· Astellas Pharma Global Development, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP1617, covering 2024-10-23 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect [Phase 1]

See pricing